This study provides evidence that SLC2A9 splice variants act as high-capacity urate transporters and is one of the first functional characterisations of findings from genome-wide association scans. We did not find an association of the SLC2A9 gene with blood pressure in this study. Our findings suggest potential pathogenic mechanisms that could offer a new drug target for gout.
No takes yet. Share an insight, caveat, or question.
Caulfield et al. (2008) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: